BioSpace News Archive

Servier to present data at 12th Annual World Clinical Biomarkers & CDx Summit demonstrating the utility of single-cell DNA sequencing with Tapestri ® in clinical development.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced a strategic collaboration with Guangzhou FineImmune Biotechnology Co., LTD. (“FineImmune”) to co-develop cell-based therapeutic drugs targeting intracellular tumor-associated antigens.

Equillium, Inc. today announced that an abstract was accepted for presentation at ACR Convergence, the annual meeting of the American College of Rheumatology.

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced it has named Jerome Bailey as the company’s new vice president of business operations.

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), (“Processa” or “Company”), a clinical stage biopharmaceutical company focused on developing products to improve survival and/or quality of life for patients who have an unmet medical need condition for which there are few or no therapeutic options, today provided an update on enrollment across all its clinical programs.

RELIEF THERAPEUTICS Holding SA reported its results for the half-year ended June 30, 2022 and provided a corporate update.

The Forever Healthy Foundation is pleased to announce the Rejuvenation Startup Summit 2022 program and full speaker list.

Pharnext SA announces that findings on the symptom burden of Charcot-Marie-Tooth Disease Type 1A from the ‘Real-World’ Digital Lifestyle Study, CMT&Me, will be presented in three poster presentations at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine 2022.

Ascletis Pharma Inc. announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus infection has completed the enrollment of 15 HIV infected patients.

Quest Diagnostics, the world’s leading provider of diagnostic information services, and Lee Health, Southwest Florida’s primary community-owned health system, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors.